Related Experiment Video
Updated: Sep 15, 2025

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.6K
Protein Tyrosine Kinase 2 Circular RNA Promotes Proliferation and Invasion of Bladder Cancer
Jingyi Cao1, Guangyue Wang1, Yan Zhao1
1Department of Urology, Xuzhou Cancer Hospital, Affiliated Hospital of Jiangsu University, Xuzhou, China.
Summary
Regulating circular RNA PTK2 (circPTK2) impacts bladder cancer cell growth and spread. Modulating circPTK2 shows potential for improving bladder cancer treatment and patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Bladder cancer significantly impacts patient quality of life and incurs high healthcare costs.
- Current treatments for bladder cancer have limitations, including adverse effects and recurrence risks.
- Circular RNAs are implicated in cancer progression and represent potential therapeutic targets.
Purpose of the Study:
- To investigate the role of circPTK2 in bladder cancer progression.
- To evaluate the therapeutic potential of modulating circPTK2 expression in bladder cancer.
Main Methods:
- Established overexpression and knockdown models for circPTK2 in bladder cancer cell lines (SW780, UM-UC-3).
- Conducted various cell function assays including proliferation (MTT, EdU, cell clone), invasion (Transwell), cell cycle, and apoptosis analysis.
- Utilized RT-qPCR to assess gene expression levels.
Main Results:
- CircPTK2 expression levels were found to correlate with mir129-5p abundance in bladder cancer cells.
- Knockdown of circPTK2 suppressed bladder cancer cell proliferation and invasion.
- Conversely, increased circPTK2 expression enhanced these cancer progression processes.
Conclusions:
- CircPTK2 plays a critical role in regulating bladder cancer progression.
- Modulating circPTK2 offers a potential strategy for bladder cancer treatment and improving patient prognosis.
Related Concept Videos
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Receptor Tyrosine Kinases
14.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.3K

